Dose reduction does not impact precision of CT-RSA in tibial components in total knee arthroplasty: a randomized controlled trial
Clinicaltrials.gov identifier NCT05651009. Initial release of the study was November 23, 2022. At that time, the software CTMA (Sectra) did not provide the very important Maximum Total Point Motion (MTPM), this was introduced in a later update of the CTMA. Hence there was change in the original protocol retrospectively.
Authors
- Otto Schnell Husby
- Tommy Frøseth Aae (ORCID: https://orcid.org/0000-0003-3643-0822)
- Are Hugo Pripp (ORCID: https://orcid.org/0000-0002-1678-7309)
- Lars H. W. Engseth (ORCID: https://orcid.org/0000-0001-8254-5765)
- Anselm Schulz (ORCID: https://orcid.org/0000-0001-7406-5497)
- Frank-David Øhrn
- Vigdis Schnell Husby
- Stephan M. Röhrl
- Fredrik Bru
Institutions
- Oslo University Hospital (NO)
- OsloMet – Oslo Metropolitan University (NO)
- University of Oslo (NO)
- Norwegian University of Science and Technology (NO)
- Ålesund Hospital (NO)
- Helse Møre og Romsdal HF (NO)
Publication Details
- Journal
- Journal of Orthopaedic Surgery and Research
- Published
- 2026-03-16
- DOI
- https://doi.org/10.1186/s13018-026-06801-8
- Primary Topic
- Total Knee Arthroplasty Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00